Looking back at 2025: the year embedded finance eroded traditional banks’ moat
Banks have enjoyed a formidable moat built on customer relationships, regulatory privilege, and distribution networks for decades. – but that moat was breached
Crypto M&A deals hit record $8.6B in 2025: what to expect in 2026?
The cryptocurrency space witnessed a major adoption curve in 2025, with mergers and acquisitions hitting a fresh record. Across the ecosystem, there were
How crypto ETFs are redefining the crypto market: key ETFs to watch heading into 2026
Cryptocurrency exchange‑traded funds (ETFs), often referred to as crypto ETFs, have shifted from niche experiment to a central pillar in the digital assets
Looking back at 2025: the year embedded finance eroded traditional banks’ moat
Banks have enjoyed a formidable moat built on customer relationships, regulatory privilege, and distribution networks for decades. – but that moat was breached
Crypto
Hoskinson Predicts Cardano DEXes Could 100X With Infrastructure Upgrades
Hoskinson encourages investors to accumulate positions on Cardano DEXes now NIGHT token generated $4.3M Cardano DEX volume, $4.2B centralized exchange volume Founder states
Investing
Craig Hemke: Silver, Gold’s “Outstanding” Year — Will 2026 Bring a Repeat?
Craig Hemke, publisher of TFMetalsReport.com, shares his thoughts on the gold and silver markets heading into 2026, outlining why he remains bullish. ‘Just
Investing
Altius Minerals to Expand Portfolio with C$520 Million Lithium Royalty Deal
Altius Minerals (TSX:ALS,OTCQX:ATUSF) is making a bet on a lithium market recovery, agreeing to acquire Lithium Royalty (TSX:LIRC) in a C$520 million deal
Investing
5 Best-performing Canadian Oil and Gas Stocks of 2025
The oil and gas sector closed 2025 amid sharp swings, as ample supply and uneven demand weighed on prices across energy markets. Crude
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally
US stocks held steady on Christmas Eve, with the broad market opening virtually flat. The Dow edged marginally higher, while the Nasdaq Composite
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat
Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use